Category WHO

Concern Erupts Over WTO System And Medicines Shipments; TRIPS Talks Rekindling

By William New The ambassadors to the World Trade Organization from Brazil and India on Tuesday charged that other WTO members had no grounds to block legitimate shipping of generic medicines on the basis of potential intellectual property rights conflicts…

New International Pharma Industry Leader Brings Prospect Of Change

By William New
Alicia Greenidge represents a change for the global pharmaceutical and biotechnology industry, but as she grows into her role as the head of the industry's international trade association, it is unclear whether there will be substantive changes on policy relating to intellectual property and public health. Key policy areas include counterfeit medicines and funding for research and development into diseases afflicting poor populations in ways that echo past industry approaches, but Greenidge brings a new focus on networking and negotiation.

Counterfeit Medication, R&D Financing Key IP Issues At WHO Board Meeting

By Kaitlin Mara The Executive Board of the World Health Organization meets next week with significant discussion expected on a new secretariat report on counterfeit medical products as well as on the implementation of the WHO’s mandated global strategy on…

US IP Attachés Take Hard-Line Position On Overseas IP Enforcement

By Drew Clark for Intellectual Property Watch WASHINGTON, DC – Nations ranging from Brazil to Brunei to Russia are failing to properly protect the intellectual property assets of US companies and others, and international organisations are not doing enough to…